Upgrade to SI Premium - Free Trial

Alnylam Pharmaceuticals, Inc. (ALNY) Tops Q2 EPS by 6c

August 8, 2013 4:29 PM
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) reported Q2 EPS of ($0.29) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings

Next Articles